These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8584652)

  • 1. Effects of transient global ischemia and a monoamine oxidase inhibitor ifenprodil on rat brain monoamine metabolism.
    Tadano T; Yonezawa A; Oyama K; Kisara K; Arai Y; Togashi M; Kinemuchi H
    Prog Brain Res; 1995; 106():173-80. PubMed ID: 8584652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rat brain monoamine oxidase activity by cerebral anti-ischemic agent, ifenprodil.
    Arai Y; Nakazato K; Kinemuchi H; Tadano T; Satoh N; Oyama K; Kisara K
    Neuropharmacology; 1991 Jul; 30(7):809-12. PubMed ID: 1922690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of type A monoamine oxidase in the activated deamination of brain monoamines shortly after reperfusion in rats.
    Kumagae Y; Matsui Y; Iwata N
    Jpn J Pharmacol; 1990 Dec; 54(4):407-13. PubMed ID: 2087001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
    Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.
    Bel N; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):475-82. PubMed ID: 7543977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
    J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites.
    Phebus LA; Clemens JA
    Life Sci; 1989; 44(19):1335-42. PubMed ID: 2469926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
    Hurst JH; Kulakowski EC
    Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of mild hypothermia plus ifenprodil on apoptosis inducing factor translocation after global cerebral ischemia-reperfusion in rats].
    Zou Y; Zhou Y; Gao W; Zeng Q; Hui K; Xu M; Duan M; Xu J
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(17):1353-6. PubMed ID: 25142861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT; Tuomainen P
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
    Waldmeier PC; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic ethanol treatment on monoamine levels in rat hippocampus and striatum.
    Vasconcelos SM; Cavalcante RA; Aguiar LM; Sousa FC; Fonteles MM; Viana GS
    Braz J Med Biol Res; 2004 Dec; 37(12):1839-46. PubMed ID: 15558190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
    Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.